Helius Medical Technologies (NASDAQ: HSDT) is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic diseases.
The company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS(R)) device. PoNS is an innovative non-surgical medical device that delivers electrical stimulation to the surface of the tongue to improve balance and gait. The PoNS device is indicated for use in North America as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis and in Canada for use as a short-term treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury and is to be used as an adjunct to a supervised therapeutic exercise program. For more information, visit www.PonsTherapy.com. For more information, visit the company’s website at www.HeliusMedical.com.
To schedule a one-on-one meeting, please contact your ROTH MKM representative.
To view IBN’s coverage of the conference, visit https://ibn.fm/Roth2023
About IBN’s Coverage
IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at 35th Annual Roth Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorBrandNetwork.com
Los Angeles, California